COM:MERRIMACK
Merrimack Pharmaceuticals
- Privately Held
news impact assignment basic | general | |||||
public peers | general | Sep 17, 2024 6:07 AM | 5b57e234 | |||
news daily refresh | general | |||||
news processing daily refresh | general | |||||
news impact assignment daily | general | |||||
news processing basic | general | Sep 17, 2024 8:29 AM | d2aac7fd | |||
company summary | general | |||||
signals | general | Sep 17, 2024 6:07 AM | efdf45e7 | |||
crunchbase trigger | general | Nov 12, 2024 12:52 PM | c5627e7c | |||
crunchbase profile | general | |||||
li profile | general | |||||
translate crunchbase fundingrounds | general | |||||
peers | general | Sep 17, 2024 6:07 AM | 6c3071d6 | |||
news basic | general | Sep 17, 2024 6:07 AM | 18cf46eb | |||
bundesanzeiger | filings | |||||
merger acquisitions | company_analysis | |||||
financials download nd | financials | |||||
private financials | financials |
e8534264-df01-4132-9f2e-73046b0deb68